Sport Climbing With Parkinson's Disease

Not Applicable

Completed

• Conditions: Parkinson Disease
• Interventions: Other: Climbing; Other: Unsupervised activity group

• Registration Number: NCT04569981
• Lead Sponsor: Medical University of Vienna

Brief Summary

This controlled interventional study will investigate the effects of a 12-weeks sport climbing course compared to 24 weeks of unsupervised physical exercise on motor symptoms in Parkinson's disease

Detailed Description

The primary aim of this study is to evaluate the effects of a 12-week sport climbing course versus unsupervised physical exercise on motor symptoms in patients with Parkinson's disease.

Background: Sport climbing (SC) is known as a whole-body workout, which additionally trains cognitive, mental, and social abilities. In contrast to its public image, SC in a controlled environment using "top-rope" belay, is a safe sport and can be performed at any age and at any level. In the field of neurological rehabilitation, it is already used as "therapeutic SC" for other neurological diseases, such as stroke, multiple sclerosis, depressions etc. but studies on climbing in PD patients are lacking.

Hypothesis: to find significant improvement of motor symptoms in the climbing group compared to the control group as well as biopsychosocial improvements after 6 weeks, 12 weeks, and 6 months after the intervention.

Methods: Effects of SC on motor symptoms in 48 PD patients in total, who will be randomized into a climbing group (n=24) and a control group (n=24) will be evaluated. The climbing group will follow a 12-week 90 min/week climbing trainings course, led by professional climbing instructors.

The control group will receive education/information material of the European physiotherapy guidelines for physical activity recommended by the WHO and will be instructed to follow the recommendation of the guidelines to independently live an active lifestyle and train unsupervised. All patients will be evaluated with clinical assessments at baseline, in between the study period (mid), after completing the 12-weeks study period (post). As additional outcomes, health benefits of SC in PD with a holistic approach, covering biopsychosocial aspects will be investigated. Therefore, non-motoric and motoric parameters will be evaluated, and follow-up assessments 6 months after.

Study Timeline

• Study Start: 2018-06-05
• Primary Completion: 2019-07-29
• Study Completion: 2019-07-29
• Study First Submitted: 2020-08-17
• Status Verified: 2020-09
• Study First Submitted QC: 2020-09-27
• Last Update Submitted: 2020-09-27
• Study First Posted: 2020-09-30
• Last Update Posted: 2020-09-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• Idiopathic Parkinson's disease
• HY stage 1-3

Read More

Exclusion Criteria

• cognitive impairment
• severe hearing or visual impairment
• severe orthopedic problems

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Climbing Group (CG)	Climbing	The patients in the Climbing Group (CG) followed a 12-weeks long climbing trainings course in small groups of 3-4 participants with a certified climbing instructor.
Unsupervised active group (UAG)	Unsupervised activity group	The patients in the unsupervised activity group (UAG) received education European physiotherapy guidelines for physical activity recommended by the WHO of recommended activity and followed their self-selected activities over 12 weeks.

Primary Outcome Measures

Name	Time	Method
Clinical Rating	Testpoints: Change from Baseline Score after 12 weeks of the intervention	Motor Part of the Movement Disorders Society Unified Parkinson Disease Rating Scale (MDS-UPDRS) III

Secondary Outcome Measures

Name	Time	Method
Change in Gait and Balance using wearable sensors	Testpoints: Change after 12 weeks of the intervention	Inertial Sensors will be used to quantify gait metrics (postural sway, gait cycle, speed) as participants conduct walking and balance trials
Quantified Bradykinesia test	Testpoints: Change after 12 weeks of the intervention	Changes in a quantified bradykinesia Tests by using a standardized speeded keyboard tapping task. Changes will be evaluates in keys/second
Hand grip strength	Testpoints: Change after 12 weeks of the intervention	Assessment of hand grip strength, using a dynamometer. Results will be evaluated in Kilogramms
Parkinson Quality of Life Questionaire-39 (PDQ-39)	Testpoints: Change after 12 weeks of the intervention	Quality of life, assessed by the PDQ-39 Questionnaire
Social Outcomes	Testpoints: Change after 12 weeks of the intervention	Questionnaiers about social effects
Cognitive assessments	Testpoints: Change after 12 weeks of the intervention	Change in cognition will be assessed using a standardized cognitive assessment battery, measuring following domains: executive functions, memory, attention and verbal functions
Changes in brain functional and structural MRI (resting state paradigma) and Changes in brain structural and functional MRI	Testpoints: Change after 12 weeks of the intervention	Changes in structural and functional MRI (resting state paradigma) will be assessed

Trial Locations

Locations (1)

Medical University of Vienna, Department of Neurology; 🇦🇹 Vienna, Austria